RCM
CHE icon

Raleigh Capital Management’s Chemed CHE Stock Holding History

Raleigh Capital Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$543 – 1011
2024
Q2 		$543 Sell
1
-44
-98% -$25.2K ﹤0.01% 899
2024
Q1 		$28.9K Buy
+45
New +$27.3K 0.01% 377
2023
Q4 		– Sell
-14
Closed -$7.28K – 1094
2023
Q3 		$7.28K Buy
+14
New +$7.28K ﹤0.01% 610

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Raleigh Capital Management's CHE Position: Q3 2024 in Review

Raleigh Capital Management sold out of Chemed (CHE) in Q3 2024, closing a stake of 1 share — an estimated $543 sold.

Raleigh Capital Management first reported a position in CHE in Q3 2023 and held it in 3 quarters. The position peaked at $28.9K in Q1 2024. 528 funds tracked by Wall St. Rank hold CHE as of Q3 2024.

  • Raleigh Capital Management reported no remaining Chemed position as of Q3 2024 after selling out during the quarter.
  • Raleigh Capital Management sold 1 Chemed share in Q3 2024, an estimated $543.
  • Raleigh Capital Management first reported a position in Chemed in Q3 2023 and held it in 3 quarters.
  • Raleigh Capital Management's Chemed position peaked at $28.9K in Q1 2024.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q3 2024.

Based on Raleigh Capital Management's 13F filing for Q3 2024, filed 21 Oct 2024.